H. Curlin

ORCID: 0000-0001-8252-418X · 10 papers in corpus
nonrandomized-trial 2022
International journal of women's health ·doi:10.2147/ijwh.s371044

STUDY OBJECTIVE: To examine long-term outcomes from the pivotal study that evaluated the safety and effectiveness of the Cerene® Cryotherapy Device (Channel Medsystems, Berkeley, CA) in premenopausal women with heavy menstrual bleeding due …

2021
·doi:10.1016/j.jmig.2021.09.416
nonrandomized-trial 2020
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2020.08.013

STUDY OBJECTIVE: To evaluate the safety and effectiveness of a novel cryoablation device (Cerene Cryotherapy Device, Channel Medsystems, Emeryville, CA) in premenopausal women with heavy menstrual bleeding owing to benign causes. DESIGN: A…

observational 2014
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2014.10.010

STUDY OBJECTIVE: To compare nerve fiber density in the cervices removed by trachelectomy from women with pelvic pain with those cervices removed for nonpain indications. DESIGN: Retrospective cohort study (Canadian Task Force classificatio…

observational 2013
·doi:10.1097/01.ogx.0000441142.43797.13

Endometrial ablation is a well-established minimally invasive gynecologic procedure for the treatment of abnormal uterine bleeding in premenopausal women. However, 16% of women have persistent abnormal bleeding or pain after ablation and fa…

observational 2013
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2013.04.006

STUDY OBJECTIVE: To determine which patient characteristics are associated with an increased risk of postablation pelvic pain. DESIGN: Canadian Task Force classification II-2. METHODS: Data were collected from a retrospective cohort of pa…

2012
·doi:10.1016/j.jmig.2012.08.713
2012
·doi:10.1016/j.jmig.2012.08.074
2011
·doi:10.1016/j.jmig.2011.08.094
2011
·doi:10.1016/j.jmig.2011.08.394